STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Neumora Therapeutics, Inc.

Filed

September 29, 2023

Period of Report

September 28, 2023

Accession Number

0001062993-23-018632